CNS vasculitis in a patient with MS on daclizumab monotherapyOHAYON, Joan; OH, Unsong; RICHERT, Nancy et al.Neurology. 2013, Vol 80, Num 5, pp 453-457, issn 0028-3878, 5 p.Article

Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genesWANDINGER, Klaus-Peter; STÜRZEBECHER, Claus-Steffen; BIELEKOVA, Bibiana et al.Annals of neurology. 2001, Vol 50, Num 3, pp 349-357, issn 0364-5134Article

Daclizumab-induced adverse events in multiple organ systems in multiple sclerosisJIWON OH; SAIDHA, Shiv; CORTESE, Irene et al.Neurology. 2014, Vol 82, Num 11, pp 984-988, issn 0028-3878, 5 p.Article

Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple SclerosisBIELEKOVA, Bibiana; HOWARD, Thomas; PACKER, Amy N et al.Archives of neurology (Chicago). 2009, Vol 66, Num 4, pp 483-489, issn 0003-9942, 7 p.Article

Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood-brain barrier disruption in multiple sclerosisBIELEKOVA, Bibiana; RICHERT, Nancy; HOWARD, Thomas et al.Multiple sclerosis. 2009, Vol 15, Num 10, pp 1206-1214, issn 1352-4585, 9 p.Article

Evolution of tumefactive lesions in multiple sclerosis: A 12-year study with serial imaging in a single patientIKONOMIDOU, Vasiliki N; RICHERT, Nancy D; VORTMEYER, Alexander et al.Multiple sclerosis. 2013, Vol 19, Num 11, pp 1539-1543, issn 1352-4585, 5 p.Article

Evolution of the Blood-Brain Barrier in Newly Forming Multiple Sclerosis LesionsGAITAN, María I; SHEA, Colin D; EVANGELOU, Lordanis E et al.Annals of neurology. 2011, Vol 70, Num 1, pp 22-29, issn 0364-5134, 8 p.Article